Roosevelt Investment Group Inc. Has $26.37 Million Holdings in Johnson & Johnson (JNJ)

Roosevelt Investment Group Inc. lowered its holdings in Johnson & Johnson (NYSE:JNJ) by 4.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 202,839 shares of the company’s stock after selling 9,656 shares during the quarter. Johnson & Johnson accounts for 2.4% of Roosevelt Investment Group Inc.’s holdings, making the stock its 5th largest holding. Roosevelt Investment Group Inc.’s holdings in Johnson & Johnson were worth $26,371,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Harding Loevner LP purchased a new stake in Johnson & Johnson in the second quarter valued at $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in Johnson & Johnson by 29.9% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after purchasing an additional 200 shares during the period. IHT Wealth Management LLC raised its holdings in shares of Johnson & Johnson by 46.4% in the 2nd quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after buying an additional 3,467 shares during the period. Mountain Capital Investment Advisors Inc purchased a new stake in shares of Johnson & Johnson in the 2nd quarter valued at $124,000. Finally, Shine Investment Advisory Services Inc. purchased a new stake in shares of Johnson & Johnson in the 2nd quarter valued at $177,000. Institutional investors own 65.58% of the company’s stock.

Several equities research analysts recently issued reports on JNJ shares. Royal Bank of Canada reiterated a “buy” rating on shares of Johnson & Johnson in a report on Tuesday, January 9th. Credit Suisse Group set a $154.00 price objective on Johnson & Johnson and gave the company a “hold” rating in a report on Monday, January 22nd. Wells Fargo & Co reiterated an “outperform” rating and issued a $160.00 price objective (up previously from $155.00) on shares of Johnson & Johnson in a report on Friday, January 12th. Zacks Investment Research downgraded Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Tuesday, December 12th. Finally, JPMorgan Chase & Co. downgraded Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $146.16.

Johnson & Johnson (NYSE JNJ) opened at $133.15 on Tuesday. Johnson & Johnson has a one year low of $118.05 and a one year high of $148.32. The company has a market capitalization of $357,710.00, a price-to-earnings ratio of 341.41, a P/E/G ratio of 2.23 and a beta of 0.74. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Tuesday, January 23rd. The company reported $1.74 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.72 by $0.02. Johnson & Johnson had a return on equity of 27.80% and a net margin of 1.70%. The firm had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.08 billion. During the same period in the previous year, the firm posted $1.58 EPS. Johnson & Johnson’s revenue for the quarter was up 11.5% on a year-over-year basis. analysts anticipate that Johnson & Johnson will post 8.11 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be paid a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 annualized dividend and a yield of 2.52%. Johnson & Johnson’s payout ratio is 861.54%.

TRADEMARK VIOLATION NOTICE: This story was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this story on another publication, it was stolen and reposted in violation of international copyright & trademark laws. The correct version of this story can be viewed at

Johnson & Johnson Company Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with's FREE daily email newsletter.

Leave a Reply